Nov 02, 2016 11:01 am UTC| Business
DEVON, Pa., Nov. 02, 2016 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today...
JA Solar Settles Lawsuit with Hemlock
Nov 02, 2016 11:00 am UTC| Business
BEIJING, Nov. 02, 2016 -- JA Solar Holdings Co., Ltd. (Nasdaq:JASO) ("JA Solar" or the "Company"), one of the world's largest manufacturers of high-performance solar power products, today announced that it has agreed to...
KVH Industries Reports Third Quarter 2016 Results
Nov 02, 2016 11:00 am UTC| Business
MIDDLETOWN, R.I., Nov. 02, 2016 -- KVH Industries, Inc., (Nasdaq:KVHI) reported financial results for the third quarter ended September 30, 2016 today. The company will hold a conference call to discuss these results at...
Nov 02, 2016 11:00 am UTC| Business
Cancer Genetics, Inc. received CLIA approval for Focus::Renal™, a unique, highly sensitive and comprehensive NGS panel for renal cancer. Focus::Renal™ was developed as a result of multiple independent validations and...
Nov 02, 2016 11:00 am UTC| Business
ROCKVILLE, Md., Nov. 02, 2016 -- REGENXBIO Inc. (Nasdaq:RGNX), a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy based...
Antares Pharma Announces Presentations at the Sexual Medicine Society Scientific Annual Meeting
Nov 02, 2016 11:00 am UTC| Business
QUICKSHOT® TESTOSTERONE DATA HAS BEEN SELECTED FOR BOTH ORAL AND POSTER PRESENTATIONS EWING, N.J., Nov. 02, 2016 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that data from the 52 week phase 3 study of the...
ADP Reports First Quarter Fiscal 2017 Results
Nov 02, 2016 11:00 am UTC| Business
Revenues increased 7% to $2.9 billion for the quarter, 8% on a constant dollar basisDiluted earnings per share from continuing operations increased 13% to $0.81; adjusted diluted earnings per share from continuing...